Find out all about your favorite commercial!

What the Pharmaceutical Research and Manufacturers of America (PhRMA) TV commercial - Negotiating Prices is about.

Title: PhRMA TV Spot: Unraveling the Complexity of Negotiating Prices

Introduction:In the realm of pharmaceuticals, one vital organization that strives to advance medical innovation and improve patient access to life-saving drugs is the Pharmaceutical Research and Manufacturers of America (PhRMA). Esteemed for its commitment to promoting better health outcomes, PhRMA never ceases in its efforts to address some of the most critical challenges faced by patients, healthcare providers, and the industry as a whole. One of its recent endeavors includes a thought-provoking TV spot titled 'Negotiating Prices.' In this article, we delve into the compelling narrative of this TV spot, exploring the core message, its impact on the healthcare landscape, and the strides taken by PhRMA to ensure access to affordable and innovative medicines.

The Core Message:The 'Negotiating Prices' TV spot serves as a rallying cry, as PhRMA seeks to shed light on the complexity surrounding drug pricing negotiations. In a concise and visually compelling manner, the spot takes viewers on a journey into the intricacies of the pharmaceutical industry, emphasizing the multifaceted nature of drug pricing. At its heart, the advertisement unpacks the intricate issue of balancing accessibility, affordability, and innovation – three vital elements that underpin the sustainability of the industry.

Impact on the Healthcare Landscape:PhRMA recognizes the importance of ensuring that groundbreaking scientific advancements translate into affordable therapies for patients. The 'Negotiating Prices' TV spot not only underscores the challenges encountered in drug pricing but also highlights the steps taken by the organization to address them. By amplifying the discourse surrounding this contentious topic, PhRMA aims to foster a deeper understanding among policymakers, healthcare providers, and the general public — working collaboratively towards sustainable solutions that prioritize patient access without compromising future innovation.

PhRMA's Commitment:PhRMA's commitment to advancing patient care is evident in its unwavering dedication to building a healthcare system that can accommodate affordability while fostering a nurturing environment for research and development. Through advocacy efforts, collaborations, and research, PhRMA endeavors to identify policy solutions that strike a delicate balance between access to affordable medicines, incentivizing innovation, and sustaining the future of medical breakthroughs.

Conclusion:In a television spot that captivates viewers with its clarity and visual storytelling, PhRMA's 'Negotiating Prices' TV spot encapsulates the multifaceted challenge of drug pricing negotiations. It serves as a reminder that the process of developing and delivering life-saving medications is far from simple,

Pharmaceutical Research and Manufacturers of America (PhRMA) TV commercial - Negotiating Prices produced for Pharmaceutical Research and Manufacturers of America (PhRMA) was first shown on television on September 19, 2021.

Frequently Asked Questions about pharmaceutical research and manufacturers of america (phrma) tv spot, 'negotiating prices'

Under the new law, Medicare for the first time will be able to directly haggle with drugmakers over prices for the costliest medications to drive down the high cost of prescription drugs for older people.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer and healthier lives.

PhRMA's lawsuit claims that the IRA's excise tax, imposed on any drugmaker that doesn't comply with Medicare's price-setting negotiations, violates the Eighth Amendment's Excessive Fines Clause.

The manufacturer sets a sticker price. But that's not the price most drug distributors pay for it. That's because distributors are able to negotiate lower prices and receive rebates and other incentives. A rebate can be paid by the manufacturer to the distributor as part of their final negotiated price.

The government can only negotiate for the drugs that Medicare spends the most on - the top 50 retail prescription drugs and the top 50 administered by physicians. The price cuts don't apply to other purchasers like private insurers or patients paying cash.

Six ways we're lowering drug prices

  1. Generic Medications. That's why the Blues launched a partnership with Civica Inc.
  2. Cancer Treatment. The first of these generics is abiraterone acetate - a generic medication used to treat prostate cancer.
  3. Insulin.
  4. Advanced Therapies.
  5. Research and Development.
  6. Advocacy.

(PHRMA dues are $75 per year).

About 92 percent of prescription drugs in the United States are distributed through wholesalers, with three - AmerisourceBergen, Cardinal Health, and McKesson Corporation - accounting for more than 90 percent of wholesale drug distribution in the United States.

In 2012, GlaxoSmithKline (GSK) agreed to a $3 billion settlement. It was the largest health care fraud settlement in U.S. history. The charges stemmed from certain prescription drugs, including Paxil, Wellbutrin and Avandia. GSK still ranks in the top ten for its pharmaceutical drug profits.

Pharmaceutical fraud Pharmaceutical fraud remains a major challenge for the industry - and it was possibly even worse during COVID-19. For manufacturers, taking steps to prevent fraud and encouraging internal discussions about potentially fraudulent behavior will help prevent issues with healthcare fraud.

When pricing their drugs, pharmaceutical companies consider a drug's uniqueness and effectiveness as well as competition from other companies. Companies also consider the research and development (R&D) costs required to bring a drug to market.

Pharmaceutical companies add a markup to the production cost, which can range from 50% to 500%, to set the drug's price. Value-based pricing is a pricing strategy used in the pharmaceutical industry that sets the price of a drug based on its perceived value to the patient.

Videos

Watch Pharmaceutical Research and Manufacturers of America (PhRMA) TV Commercial, 'Negotiating Prices'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Advertisers

Advertisers of the Pharmaceutical Research and Manufacturers of America (PhRMA) TV Spot, 'Negotiating Prices'

Pharmaceutical Research and Manufacturers of America (PhRMA) TV commercial - Negotiating Prices
Pharmaceutical Research and Manufacturers of America (PhRMA)

The Pharmaceutical Research and Manufacturers of America (PhRMA) is a trade association representing the research-based pharmaceutical and biotechnology companies in the United States. It serves as th...

TV commercials

Similar commercials

PhRMA TV Spot, 'Together: Alzheimer’s Disease'
PhRMA TV Spot, 'Protect Patients'
184 January 31, 2022
PhRMA TV Spot, 'Middlemen'
606 December 4, 2021
American Back and Knee Center TV Spot, 'Back and Knee Braces'
PhRMA TV Spot, 'Together: Heart Transplant'
Pharmaceutical Research and Manufacturers of America (PhRMA) TV Spot, 'Cooper’s Hope'
Back and Knee Brace Center TV Spot, 'Covered by Medicare'
Back and Knee Brace Center TV Spot, 'Back or Knee Pain: Braces'
BASF TV Spot, 'The Future Is What You Make'
Back and Knee Brace Center TV Spot, 'Testimonies'
50 Floor TV Spot, 'Lil' Tax Deductions: Free Install' Featuring Richard Karn
50 Floor TV Spot, 'Newest Flooring: 60 Off' Featuring Richard Karn